Lv4
750 积分 2024-10-16 加入
Immunotherapy in acute myeloid leukemia: The antibodies, TriKEs, and CARs on the arduous road to cure
9天前
已关闭
Multiple infusions of TILs expanded with IL-2/IL-15/IL-21 lead to an improved PK/PD profile and long-term clinical responses in patients with cold tumors
26天前
已完结
Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles
2个月前
已完结
Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
2个月前
已完结
The dawn of in vivo immune cell engineering in oncology
2个月前
已完结
Controlling the biodistribution and clearance of nanomedicines
3个月前
已完结
Design principles of lipid nanoparticles for RNA delivery
3个月前
已完结
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases
3个月前
已完结
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
3个月前
已完结
Axes of biological variation in diffuse large B cell lymphoma
3个月前
已完结
皖公网安备34019202002308
